Abstract
RNA interference (RNAi)-based gene regulation has recently emerged as a promising strategy to silence genes that drive disease progression. RNAi is typically mediated by small interfering ribonucleic acids (siRNAs), which, upon delivery into the cell cytoplasm, trigger degradation of complementary messenger RNA molecules to halt production of their encoded proteins. While RNAi has enormous clinical potential, its in vivo utility has been hindered because siRNAs are rapidly degraded by nucleases, cannot passively enter cells, and are quickly cleared from the bloodstream. To overcome these delivery barriers, siRNAs can be conjugated to nanoparticles (NPs), which increase their stability and circulation time to enable in vivo gene regulation. Here, we present methods to conjugate siRNA duplexes to NPs with gold surfaces. Further, we describe how to quantify the resultant amount of siRNA sense and antisense strands loaded onto the NPs using a fluorescence-based assay. This method focuses on the attachment of siRNAs to 13 nm gold NPs, but it is adaptable to other types of nucleic acids and nanoparticles as discussed throughout the protocol.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Deng Y, Wang CC, Choy K et al (2014) Therapeutic potentials of gene silencing by RNA interference: Principles, challenges, and new strategies. Gene 538:217–227
Hill AB, Chen M, Chen C-K et al (2016) Overcoming gene-delivery hurdles: Physiological considerations for nonviral vectors. Trends Biotechnol 34(2):91–105
Chen J, Guo Z, Chen X (2016) Production and clinical development of nanoparticles for gene delivery. Mol Ther Methods Clin Dev 3:16023
Kim HJ, Kim A, Miyata K et al (2016) Recent progress in development of siRNA delivery vehicles for cancer therapy. Adv Drug Deliv Rev 104:61–77
Ding Y, Jiang Z, Saha K et al (2014) Gold nanoparticles for nucleic acid delivery. Mol Ther 22(6):1075–1083
Deng ZJ, Morton SW, Ben-Akiva E et al (2013) Layer-by-layer nanoparticles for systemic codelivery of an anticancer drug and siRNA for potential triple-negative breast cancer treatment. ACS Nano 7(11):9571–9584
Elbakry A, Zaky A, Liebl R et al (2009) Layer-by-layer assembled gold nanoparticles for siRNA delivery. Nano Lett 9(5):2059–2064
Lee J-S, Green JJ, Love KT et al (2009) Gold, poly(β-amino ester) nanoparticles for small interfering RNA delivery. Nano Lett 9(6):2402–2406
Dahlman JE, Barnes C, Khan OF et al (2014) In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight. Nat Nanotechnol 9:648–655
Lee JB, Hong J, Bonner DK et al (2012) Self-assembled RNA interference microsponges for efficient siRNA delivery. Nat Mater 11:316–322
Giljohann DA, Seferos DS, Prigodich AE et al (2009) Gene regulation with polyvalent siRNA-nanoparticle conjugates. J Am Chem Soc 131:2072–2073
Jensen SA, Day ES, Ko CH et al (2013) Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma. Sci Transl Med 5(209):209ra152
Randeria PS, Seeger MA, Wang X-Q et al (2015) siRNA-based spherical nucleic acids reverse impaired wound healing in diabetic mice by ganglioside GM3 synthase knockdown. Proc Natl Acad Sci U S A 112(18):5573–5578
Zheng D, Giljohann DA, Chenc DL et al (2012) Topical delivery of siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation. Proc Natl Acad Sci U S A 109(30):11975–11980
Barnaby SN, Lee A, Mirkin CA (2014) Probing the inherent stability of siRNA immobilized on nanoparticle constructs. Proc Natl Acad Sci U S A 111(27):9739–9744
Choi CHJ, Hao L, Narayan SP et al (2013) Mechanism for the endocytosis of spherical nucleic acid nanoparticle conjugates. Proc Natl Acad Sci U S A 110(19):7625–7630
Patel PC, Giljohann DA, Daniel WL et al (2010) Scavenger receptors mediate cellular uptake of polyvalent oligonucleotide-functionalized gold nanoparticles. Bioconjug Chem 21(12):2250–2256
Giljohann DA, Seferos DS, Patel PC et al (2007) Oligonucleotide loading determines cellular uptake of DNA-modified gold nanoparticles. Nano Lett 7(12):3818–3821
Raja MAG, Katas H, Wen TH (2015) Stability, intracellular delivery, and release of siRNA from chitosan nanoparticles using different cross-linkers. PLoS One 10(6):e1028963
Kim E-Y, Stanton J, Vega RA et al (2006) A real-time PCR-based method for determining the surface coverage of thiol-capped oligonucleotides bound onto gold nanoparticles. Nucleic Acids Res 34(7):e54
Demers LM, Mirkin CA, Mucic RC et al (2000) A fluorescence-based method for determining the surface coverage and hybridization efficiency of thiol-capped oligonucleotides bound to gold thin films and nanoparticles. Anal Chem 72:5535–5541
McKenzie F, Steven V, Ingram A et al (2009) Quantitation of biomolecules conjugated to nanoparticles by enzyme hydrolysis. Chem Commun 2009:2872–2874
Randeria PS, Jones MR, Kohlsted KL et al (2015) What controls the hybridization thermodynamics of spherical nucleic acids? J Am Chem Soc 137(10):3486–3489
Kouri FM, Hurley LA, Daniel WL et al (2015) miR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma. Genes Dev 29(7):732–745
Rosi NL, Giljohann DA, Thaxton CS et al (2006) Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science 312(5776):1027–1030
Hill HD, Millstone JE, Banholzer MJ et al (2009) The role radius of curvature plays in thiolated oligonucleotide loading on gold nanoparticles. ACS Nano 3(2):418–424
Frens G (1973) Controlled nucleation for the regulation of the particle size in monodisperse gold suspensions. Nat Phys Sci 241:20–22
Acknowledgement
The authors acknowledge support from the University of Delaware Research Foundation, the W.M. Keck Foundation, Grant IRG14-251-07-IRG from the American Cancer Society, and an Institutional Development Award (IDeA) from the National Institutes of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH) under grant number U54-GM104941. J.R.M. received support from a National Defense Science and Engineering Graduate Fellowship from the Department of Defense.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Melamed, J.R., Riley, R.S., Valcourt, D.M., Billingsley, M.M., Kreuzberger, N.L., Day, E.S. (2017). Quantification of siRNA Duplexes Bound to Gold Nanoparticle Surfaces. In: Petrosko, S., Day, E. (eds) Biomedical Nanotechnology. Methods in Molecular Biology, vol 1570. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6840-4_1
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6840-4_1
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6838-1
Online ISBN: 978-1-4939-6840-4
eBook Packages: Springer Protocols